0001209191-22-054486.txt : 20221025 0001209191-22-054486.hdr.sgml : 20221025 20221025160015 ACCESSION NUMBER: 0001209191-22-054486 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221024 FILED AS OF DATE: 20221025 DATE AS OF CHANGE: 20221025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carter Martha J. CENTRAL INDEX KEY: 0001213040 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 221329490 MAIL ADDRESS: STREET 1: C/O AEGERION PHARMACEUTICALS, INC. STREET 2: 89 HEADQUARTERS PLAZA, SUITE 1212 CITY: MORRISTOWN STATE: NJ ZIP: 07960 FORMER NAME: FORMER CONFORMED NAME: CARTER MARTHA J DATE OF NAME CHANGE: 20030106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBIREO PHARMA, INC. CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-415-4774 MAIL ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Biodel Inc DATE OF NAME CHANGE: 20050331 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-10-24 0 0001322505 ALBIREO PHARMA, INC. ALBO 0001213040 Carter Martha J. C/O ALBIREO PHARMA, INC. 53 STATE STREET, 19TH FLOOR BOSTON MA 02109 0 1 0 0 Chief Regulatory Officer Common Stock 2022-10-24 4 S 0 104 19.5764 D 15564 D Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Represents 1,670 shares of common stock and 13,894 restricted stock units. /s/ Jason Duncan, Attorney-in-fact 2022-10-25